New Customers Get 10% Off – Use Code: LUX10

GLP-2 TZ

5.0 Reviews

GLP-2Peptides

A GLP-related research peptide (TZ) studied in preclinical models for its interaction with incretin-receptor and metabolic signaling pathways. For laboratory research use only.

All products currently listed on this site are for research purposes only.

Original price was: $139.99.Current price is: $125.99.

2 Day FAST Shipping

99%+ Purity Tests

Ships from USA

USA Lab Tested

We accept :

Certificate of Analysis

Third Party Tested by Freedom Diagnostics

How GLP-2 TZ Works

The Science, Simplified

Research Peptide

Tirzepatide is characterized in research literature as a dual agonist with affinity for both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors.
Key observation: Where single-target peptides interact only with the GLP-1 pathway, the added GIP component broadens receptor engagement. In preclinical models, GIP has been observed to act alongside GLP-1 at the incretin-receptor level, a mechanism studied for its role in signaling pathway research.

Metabolic Pathway Modulation

In research models, Tirzepatide is studied for its interaction with pathways governing cellular energy signaling.

Key observation: In published preclinical and receptor research, including the SURPASS and SURMOUNT research programs, this dual-receptor agonism has been characterized as a distinct signaling profile. The compound is studied as a subject of incretin-receptor research, including its observed influence on glucose-handling pathways in skeletal muscle models.

Hepatic & Cardiovascular Pathways (Research Models)

Research increasingly examines Tirzepatide's interaction with hepatic and cardiovascular signaling pathways in preclinical models.

Key observation: In preclinical research, changes in hepatic lipid content and inflammatory markers have been recorded. The compound is a subject of study for its observed association with LDL cholesterol and triglyceride markers in research models, making it a subject of interest in cardiovascular and non-alcoholic fatty liver disease (NAFLD) pathway research.

Research Handling Notes

What research literature describes

Tirzepatide is a well-characterized research peptide handled as a stable compound; standard laboratory handling applies given its high potency.

🧿 Handling & Storage Notes

18%

Store lyophilized at -20°C

mild

17%

Reconstitute with bacteriostatic water

mild

10%

Protect from light exposure

mild

Research Characteristics

Non-Suppressive Elevation

  • Glucose-Dependent Mechanism: In research models, Tirzepatide's interaction with insulin-secretory pathways is characterized as glucose-dependent, a mechanism of interest in incretin-receptor studies.
  • Stable Half-Life: The compound is reported to have a half-life of approximately 5 days, a property of interest for maintaining consistent steady-state levels in a laboratory setting.
  • Renal Pathway Research: Emerging preclinical research examines Tirzepatide's interaction with renal signaling pathways in metabolic research models.

Compound Information

Technical specifications for this 39aa dual agonist

🔬 Molecular Profile

What Is GLP-2 TZ?

Full Name

Tirzepatide (GLP-2 TZ)

Peptide Type

GIP / GLP-1 Dual Agonist

Sequence

39-Amino Acid Linear Peptide

Molecular Weight

4813.45 g/mol

Formula

C225H348N48O68

🧊 Storage Requirements

Stability Information

Lyophilized (powder)

Store at -20°C

(Stable for up to 2 years).

Reconstituted

Store at 2-8°C

use within 21-28 days.

Sensitivity

Keep desiccated and away from light.

📋Research Status

Development History Observation

Classification

First-in-class Dual Agonist

Primary Goal

Glycemic Control / Obesity Research

US Status

FDA Approved (Mounjaro/Zepbound)

WADA Status

Banned (Section S2)

Frequently Asked Questions

Common questions about GLP-2 TZ

In comparative receptor research (such as the SURPASS-2 program), Tirzepatide is distinguished from Semaglutide by its dual-agonist profile, engaging two incretin-receptor pathways rather than one. This mechanistic difference is a frequent subject of laboratory research.
While technically a GLP-1/GIP agonist, some catalogs use "GLP-2" or similar naming conventions to differentiate specialized blends or versions of Tirzepatide (TZ). However, the primary biological mechanism remains the dual activation of the incretin pathways.
A 30mg Tirzepatide vial is supplied as a lyophilized powder and reconstituted with bacteriostatic water for laboratory work. The 30mg quantity offers flexibility for preparing multiple working aliquots across an extended research timeline.
In preclinical research, Tirzepatide is studied for its interaction with GLP-1 and GIP receptors expressed in central nervous system regions. These receptor pathways are a frequent subject of neurological and signaling-pathway research models.
Tirzepatide is a well-characterized compound that remains stable over extended research timelines when stored lyophilized and protected from light. Reconstituted material should be refrigerated and handled per standard laboratory protocols to preserve integrity.

Sources & References

Peer-reviewed research

  • Important Research Notice

For laboratory research use only; not for human or animal use. This product is sold exclusively for laboratory research and educational purposes. It is not a drug and is not intended to diagnose, treat, cure, or prevent any disease.

All research data and findings referenced on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.

By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.

My Account
Follow Us
Linkedin X-twitter Icon-instagram-1 Facebook-square